The clinical significance of p53 aberrations in human tumours.
about
The Gfi-1B proto-oncoprotein represses p21WAF1 and inhibits myeloid cell differentiation.Cytogenetic significance of chromosome 17 aberrations and P53 gene mutations as prognostic markers in oral squamous cell carcinomaA study of interval breast cancer within the NHS breast screening programmeAnalysis of chromosome 17p13 (p53 locus) alterations in gastric carcinoma cells by dual-color fluorescence in situ hybridization.MDM-2 oncoprotein overexpression, p53 gene mutation, and VEGF up-regulation in angiosarcomasExpression of molecular biomarkers in primary breast tumors implanted into a surrogate host: increased levels of cyclins correlate with tumor progressionTumour markers of prognosis in colorectal cancer.In squamous cell carcinoma of the vulva, overexpression of p53 is a late event and neither p53 nor mdm2 expression is a useful marker to predict lymph node metastasesPrognostic value of colorectal cancer biomarkers.Can we improve the clinical risk score? The prognostic value of p53, Ki-67 and thymidylate synthase in patients undergoing radical resection of colorectal liver metastases.What We Know about the Molecular Genetics of Central Nervous System (CNS) Tumours in Malaysia.Apoptosis in Primary Hyperparathyroidism.The cyclin D1 high and cyclin E high subgroups of breast cancer: separate pathways in tumorogenesis based on pattern of genetic aberrations and inactivation of the pRb node.Splicing mutations in TP53 in human squamous cell carcinoma lines influence immunohistochemical detection.Nested PCR-SSCP assay for the detection of p53 mutations in paraffin wax embedded bone tumours: improvement of sensitivity and fidelityP53 overexpression predicts poor chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV colorectal cancers after palliative bowel resection.Molecular assessment of p53 abnormalities at the invasive front of oral squamous cell carcinomas.p53 protein accumulation and p53 gene mutation in esophageal carcinoma. A molecular and immunohistochemical study with clinicopathologic correlations.Abnormal expression of MDM2 in prostate carcinoma.[Immunohistochemical expression of p53 protein in squamous epithelial carcinomas and normal and dysplastic epithelium of the mouth cavity].p53 immunostaining is correlated with reduced survival and is not correlated with gene mutations in resected pulmonary large cell carcinomas.Large cell lung carcinoma with unusual imaging feature, immunophenotype and genetic finding.[Fraction of gemistocytic astrocytes and immunoexpression of p53 protein in astrocytomas grade II and III (WHO)]
P2860
Q24310788-F7DD4799-5955-4894-A96F-C33460AF4735Q35122127-79986C8C-70C7-4F6B-B4C6-A163B6E9470DQ35571833-4B6D7B37-3A72-4CAE-81F8-2D50A21585ADQ35782454-11CE7FC3-6760-44EC-9F19-F5CD99A0725AQ35809398-9C39C7B3-22B1-407B-A48C-BBE9CEA02FBDQ36437747-69F51526-2FCF-4FB2-9FF8-2868D3140639Q36617345-7149C002-FEE0-4BB7-B5DF-57C79D47C655Q36620156-F12DF21A-0BD3-4B5E-AB24-8F3BAC6C478BQ37132721-51188E0F-D232-4698-884D-DBF914249DF2Q37623502-6FFF6008-FE80-4537-8FA7-310E1DA8013EQ38043443-E22C1054-36AA-4739-85B9-BC6C26684B67Q39211022-518F3E9D-4476-4837-BDDD-466E2515EC5BQ40720961-1DBE86EE-CC4E-4786-A603-46A44AA42A28Q40756350-B4D6E22C-ED6B-41EA-B860-E8B3BF55907DQ40849368-2D07EBE1-09B9-47C9-80DE-02BE23F5FFF3Q43861062-81DFE161-6BB0-4732-8EF0-47F9AF4545F1Q43919754-98B65B20-9198-4EB3-A6E3-ED896E568896Q50974656-AA1197A8-21E1-4284-A51C-5C48A9A89F69Q53398985-3103F9C1-13D7-4AED-B930-2386021AE0ABQ53445343-8C8C00AC-095F-4969-8CEC-2CCA3B356562Q53537207-885C2EF7-B625-4C6F-916D-1C59D4D44976Q54431715-D3868108-0B6A-4E06-B201-345432AC5BA2Q55473904-2C313EB8-A73E-49CD-B2D6-D3508D19DDEF
P2860
The clinical significance of p53 aberrations in human tumours.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
The clinical significance of p53 aberrations in human tumours.
@en
type
label
The clinical significance of p53 aberrations in human tumours.
@en
prefLabel
The clinical significance of p53 aberrations in human tumours.
@en
P356
P1433
P1476
The clinical significance of p53 aberrations in human tumours.
@en
P2093
P2888
P304
P356
10.1007/BF00203389
P577
1995-01-01T00:00:00Z
P6179
1003974521